📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. (2019)

First Author: Carreno G

Attributed to: Molecular and Cellular Mechanisms Underlying Pituitary Tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/erc-18-0538

PubMed Identifier: 30645190

Publication URI: http://europepmc.org/abstract/MED/30645190

Type: Journal Article/Review

Volume: 26

Parent Publication: Endocrine-related cancer

Issue: 3

ISSN: 1351-0088